These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
55 related articles for article (PubMed ID: 31931932)
41. Nutrition and anabolic pharmacotherapies in the care of burn patients. Abdullahi A; Jeschke MG Nutr Clin Pract; 2014 Oct; 29(5):621-30. PubMed ID: 25606644 [TBL] [Abstract][Full Text] [Related]
42. Current pharmacotherapy for the treatment of severe burns. Murphy KD; Lee JO; Herndon DN Expert Opin Pharmacother; 2003 Mar; 4(3):369-84. PubMed ID: 12614189 [TBL] [Abstract][Full Text] [Related]
43. Post burn muscle wasting and the effects of treatments. Pereira C; Murphy K; Jeschke M; Herndon DN Int J Biochem Cell Biol; 2005 Oct; 37(10):1948-61. PubMed ID: 16109499 [TBL] [Abstract][Full Text] [Related]
45. The role of the musculoskeletal system in post-burn hypermetabolism. Klein GL Metabolism; 2019 Aug; 97():81-86. PubMed ID: 31181216 [TBL] [Abstract][Full Text] [Related]
46. Cardiac Dysfunction in Severely Burned Patients: Current Understanding of Etiology, Pathophysiology, and Treatment. Tapking C; Popp D; Herndon DN; Branski LK; Hundeshagen G; Armenta AM; Busch M; Most P; Kinsky MP Shock; 2020 Jun; 53(6):669-678. PubMed ID: 31626036 [TBL] [Abstract][Full Text] [Related]
47. Modulation of Burn Hypermetabolism in Preclinical Models. Eldaly AS; Avila FR; Torres R; Maita K; Garcia J; Serrano L; Ho O; Forte AJ Cureus; 2023 Jan; 15(1):e33518. PubMed ID: 36779088 [TBL] [Abstract][Full Text] [Related]
48. The metabolic stress response to burn trauma: current understanding and therapies. Porter C; Tompkins RG; Finnerty CC; Sidossis LS; Suman OE; Herndon DN Lancet; 2016 Oct; 388(10052):1417-1426. PubMed ID: 27707498 [TBL] [Abstract][Full Text] [Related]
49. Burn Injury-related Growth Factor Expressions and Their Potential Roles in Burn-related Neuropathies. Chaker SC; Saad M; Mayes T; Lineaweaver WC J Burn Care Res; 2024 Jan; 45(1):25-31. PubMed ID: 37978864 [TBL] [Abstract][Full Text] [Related]
50. Burns: Classification, Pathophysiology, and Treatment: A Review. Żwierełło W; Piorun K; Skórka-Majewicz M; Maruszewska A; Antoniewski J; Gutowska I Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835171 [TBL] [Abstract][Full Text] [Related]
51. Effects of Propranolol in Accelerating Wound Healing and Attenuation of Hypermetabolism in Adult Burn Patients. Cheema SA; Ahmed UT; Nasir H; Dogar SR; Mustafa Z J Coll Physicians Surg Pak; 2020 Jan; 30(1):46-50. PubMed ID: 31931932 [TBL] [Abstract][Full Text] [Related]
53. Systematic review of the effect of propanolol on hypermetabolism in burn injuries. Núñez-Villaveirán T; Sánchez M; Millán P; García-de-Lorenzo A Med Intensiva; 2015 Mar; 39(2):101-13. PubMed ID: 25305241 [TBL] [Abstract][Full Text] [Related]
54. Effects of pharmacological interventions on muscle protein synthesis and breakdown in recovery from burns. Diaz EC; Herndon DN; Porter C; Sidossis LS; Suman OE; Børsheim E Burns; 2015 Jun; 41(4):649-57. PubMed ID: 25468473 [TBL] [Abstract][Full Text] [Related]
55. Recombinant human growth hormone for treating burns and donor sites. Breederveld RS; Tuinebreijer WE Cochrane Database Syst Rev; 2012 Dec; 12():CD008990. PubMed ID: 23235668 [TBL] [Abstract][Full Text] [Related] [Previous] [New Search]